The future is blue
The new Tracker Certificate combines 27 shares, selected by ZKB Asset Management, with exposure to hydrogen. The composition of the basket aims for a risk-diversified and efficient representation of a topic with excellent future prospects. The dynamic management ensures a continuous review of the positions. Hydrogen is at a turning point towards a positive development. The Paris Climate Agreement and a high level of political support, as well as technological advances, are driving the development. Increased demand enables the industrialisation of production and thus lower costs. Some projects are still in the research and development phase and the first pilot projects are emerging. The first vehicles, mainly trucks, with climate-friendly hydrogen propulsion are being produced.
Hydrogen offers numerous investment opportunities along the value chain - from speculative "pure plays" to broadly diversified companies. This Certificate enables participation in this dynamically developing, sustainable theme. The certificate contains partly speculative, but also long-standing equities and is particularly suitable for risk-takin investors.
The new basket in detail
The Certificate will include 27 thoroughly selected stocks with equal weighting at the initial fixing date. The broad diversification via "pure plays" and broadly positioned companies whose business activities are currently only partly focused on hydrogen offers participation in a potential megatrend with risk diversification.
Tracker Certificate Dynamic on a Hydrogen Equity Basket
▪ Diversification through large, mid and small capitalisations
▪ Without maturity ("Open End")
▪ ZKB Asset Management acts as Investment Manager
go to product
Disclaimer
This communication is for marketing purposes. It is neither an offer nor an invitation to submit an offer, to purchase or to subscribe to securities and does not constitute investment advice. You should consult your advisors before making an investment decision.
Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, financial condition, development or performance of the issuer to be materially different from any future results, financial condition, development or performance expressed or implied by such statements.
The present document has not been drawn up by the research department as defined in the rules of the “Directives on the Independence of Financial Research” published by the Swiss Bankers Association, hence these rules do not apply to this document.
If securities are mentioned in the communication, the base prospectus, the final terms and any key information document may be obtained free of charge from Zürcher Kantonalbank, Bahnhofstrasse 9, 8001 Zurich, VRIS, and from www.zkb.ch/finanzinformationen.
ZKB Barrier Reverse Convertible mit bedingtem Coupon on worst of Salesforce.com Inc/NVIDIA Corp/Supe... 132913957 / CH1329139575 |
ZKB Autocallable Barrier Reverse Convertible on worst of Biogen Inc/BioNTech SE/Moderna Inc 132913422 / CH1329134220 |
ZKB Reverse Convertible auf Moderna Inc 135805537 / CH1358055379 |
22.09% ZKB Reverse Convertible, 16.01.2025 on worst of NVDA UW/TSLA UW/MRNA UW NVIDIA Corp/Tesla Inc... 130398418 / CH1303984186 |
11.17% ZKB Reverse Convertible, 03.03.2025 on worst of QCOM UW/AAL UW/MRNA UW Qualcomm Inc/American ... 135805027 / CH1358050271 |